ENETS Consensus Recommendations for the Standards of Care in Neuroendocrine Neoplasms: Follow-Up and Documentation

U. Knigge; J. Capdevila; D. K. Bartsch; E. Baudin; J. Falkerby; R. Kianmanesh; B. Kos-Kudla; B. Niederle; E. Nieveen Van Dijkum; D. O'Toole; A. Pascher; N. Reed; A. Sundin; M. P. Vullierme; all other  Antibes Consensus Conference participants

doi:10.1159/000458155

ENETS Consensus Recommendations for the Standards of Care in Neuroendocrine Neoplasms: Follow-Up and Documentation

U. Knigge, J. Capdevila, D. K. Bartsch, E. Baudin, J. Falkerby, R. Kianmanesh, B. Kos-Kudla, B. Niederle, E. Nieveen Van Dijkum, D. O'Toole, A. Pascher, N. Reed, A. Sundin, M. P. Vullierme, all other Antibes Consensus Conference participants

Institut for Klinisk Medicin

39 Citationer (Scopus)

Abstract

ENETS consensus recommendations for the standards of care in neuroendocrine neoplasms (NEN) concerning follow-up and documentation are considered in this review. The documentation of patients with NEN should include the most relevant data characterizing an individual patient from the first contact with his/her physician/hospital until his/her last presentation during follow-up. It is advocated that follow-up occurs in specialized NEN centers with regular NEN tumor boards with expert panels. The follow-up should be in accordance with the ENETS consensus guidelines from 2011 and 2016, the present and coming WHO classification and ENETS/UICC recommendations for TNM staging. The recommendations for follow-up in patients with thymic, bronchopulmonary and gastroenteropancreatic NEN are given in Table 1. However, it should be stressed that evidence-based studies for follow-up are largely missing.

Originalsprog	Engelsk
Tidsskrift	Neuroendocrinology
Vol/bind	105
Udgave nummer	3
Sider (fra-til)	310-319
Antal sider	10
ISSN	0028-3835
DOI	https://doi.org/10.1159/000458155
Status	Udgivet - sep. 2017

Adgang til dokumentet

10.1159/000458155

Citationsformater

Knigge, U., Capdevila, J., Bartsch, D. K., Baudin, E., Falkerby, J., Kianmanesh, R., Kos-Kudla, B., Niederle, B., Nieveen Van Dijkum, E., O'Toole, D., Pascher, A., Reed, N., Sundin, A., Vullierme, M. P., & all other Antibes Consensus Conference participants (2017). ENETS Consensus Recommendations for the Standards of Care in Neuroendocrine Neoplasms: Follow-Up and Documentation. Neuroendocrinology, 105(3), 310-319. https://doi.org/10.1159/000458155

Knigge, U, Capdevila, J, Bartsch, DK, Baudin, E, Falkerby, J, Kianmanesh, R, Kos-Kudla, B, Niederle, B, Nieveen Van Dijkum, E, O'Toole, D, Pascher, A, Reed, N, Sundin, A, Vullierme, MP & all other Antibes Consensus Conference participants 2017, 'ENETS Consensus Recommendations for the Standards of Care in Neuroendocrine Neoplasms: Follow-Up and Documentation', Neuroendocrinology, bind 105, nr. 3, s. 310-319. https://doi.org/10.1159/000458155

@article{344a93dcd7d040b791229c10916abfd7,

title = "ENETS Consensus Recommendations for the Standards of Care in Neuroendocrine Neoplasms: Follow-Up and Documentation",

abstract = "ENETS consensus recommendations for the standards of care in neuroendocrine neoplasms (NEN) concerning follow-up and documentation are considered in this review. The documentation of patients with NEN should include the most relevant data characterizing an individual patient from the first contact with his/her physician/hospital until his/her last presentation during follow-up. It is advocated that follow-up occurs in specialized NEN centers with regular NEN tumor boards with expert panels. The follow-up should be in accordance with the ENETS consensus guidelines from 2011 and 2016, the present and coming WHO classification and ENETS/UICC recommendations for TNM staging. The recommendations for follow-up in patients with thymic, bronchopulmonary and gastroenteropancreatic NEN are given in Table 1. However, it should be stressed that evidence-based studies for follow-up are largely missing.",

keywords = "5-Hydroxyindoleacetic acid, Chromogranin A, Follow-up, Functional imaging, Neuroendocrine carcinoma, Neuroendocrine neoplasm, Neuroendocrine tumor, Neuron-specific enolase, NT-pro-brain natriuretic peptide, Somatostatin receptor imaging, TNM staging",

author = "U. Knigge and J. Capdevila and Bartsch, {D. K.} and E. Baudin and J. Falkerby and R. Kianmanesh and B. Kos-Kudla and B. Niederle and {Nieveen Van Dijkum}, E. and D. O'Toole and A. Pascher and N. Reed and A. Sundin and Vullierme, {M. P.} and {all other Antibes Consensus Conference participants}",

year = "2017",

month = sep,

doi = "10.1159/000458155",

language = "English",

volume = "105",

pages = "310--319",

journal = "Neuroendocrinology",

issn = "0028-3835",

publisher = "S Karger AG",

number = "3",

}

TY - JOUR

T1 - ENETS Consensus Recommendations for the Standards of Care in Neuroendocrine Neoplasms

T2 - Follow-Up and Documentation

AU - Knigge, U.

AU - Capdevila, J.

AU - Bartsch, D. K.

AU - Baudin, E.

AU - Falkerby, J.

AU - Kianmanesh, R.

AU - Kos-Kudla, B.

AU - Niederle, B.

AU - Nieveen Van Dijkum, E.

AU - O'Toole, D.

AU - Pascher, A.

AU - Reed, N.

AU - Sundin, A.

AU - Vullierme, M. P.

AU - all other Antibes Consensus Conference participants

PY - 2017/9

Y1 - 2017/9

N2 - ENETS consensus recommendations for the standards of care in neuroendocrine neoplasms (NEN) concerning follow-up and documentation are considered in this review. The documentation of patients with NEN should include the most relevant data characterizing an individual patient from the first contact with his/her physician/hospital until his/her last presentation during follow-up. It is advocated that follow-up occurs in specialized NEN centers with regular NEN tumor boards with expert panels. The follow-up should be in accordance with the ENETS consensus guidelines from 2011 and 2016, the present and coming WHO classification and ENETS/UICC recommendations for TNM staging. The recommendations for follow-up in patients with thymic, bronchopulmonary and gastroenteropancreatic NEN are given in Table 1. However, it should be stressed that evidence-based studies for follow-up are largely missing.

AB - ENETS consensus recommendations for the standards of care in neuroendocrine neoplasms (NEN) concerning follow-up and documentation are considered in this review. The documentation of patients with NEN should include the most relevant data characterizing an individual patient from the first contact with his/her physician/hospital until his/her last presentation during follow-up. It is advocated that follow-up occurs in specialized NEN centers with regular NEN tumor boards with expert panels. The follow-up should be in accordance with the ENETS consensus guidelines from 2011 and 2016, the present and coming WHO classification and ENETS/UICC recommendations for TNM staging. The recommendations for follow-up in patients with thymic, bronchopulmonary and gastroenteropancreatic NEN are given in Table 1. However, it should be stressed that evidence-based studies for follow-up are largely missing.

KW - 5-Hydroxyindoleacetic acid

KW - Chromogranin A

KW - Follow-up

KW - Functional imaging

KW - Neuroendocrine carcinoma

KW - Neuroendocrine neoplasm

KW - Neuroendocrine tumor

KW - Neuron-specific enolase

KW - NT-pro-brain natriuretic peptide

KW - Somatostatin receptor imaging

KW - TNM staging

U2 - 10.1159/000458155

DO - 10.1159/000458155

M3 - Comment/debate

C2 - 28222443

AN - SCOPUS:85013636507

SN - 0028-3835

VL - 105

SP - 310

EP - 319

JO - Neuroendocrinology

JF - Neuroendocrinology

IS - 3

ER -

ENETS Consensus Recommendations for the Standards of Care in Neuroendocrine Neoplasms: Follow-Up and Documentation

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater